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ABSTRACT
Background: Insomnia is common in service members and associated with many mental
and physical health problems. Recently, longitudinal data have been used to assess the
impact of disturbed sleep on mental health outcomes. These studies have consistently
shown relationships between sleep disturbance and development of mental illness.
Objective: The present study examined the longitudinal relationship between sleep
disturbance and PTSD symptomatology in a cohort of Marines and Navy Corpsmen
deployed to Iraq and Afghanistan (n = 2,404) assessed prior to deployment, as well as
at −3 and 6 months post-deployment. Additionally, we aimed to investigate the extent
to which these relationships are moderated by combat-stress severity, and to what
extent these findings are replicated in a second, separate cohort of Marines and Navy
corpsmen (n = 938) assessed with identical measures prior to deployment and within 3
months of return.
Method: The present study employed latent variable path models to examine the
relationships between pre-deployment sleep disturbance and post-deployment re-
experiencing symptoms. Initial cross-lagged path models were conducted on discovery
and replication samples to validate the hypothesized predictive relationships. Follow up
moderation path models were then conducted to include the effect of combat-stress
severity on these relationships.
Results: Initial cross-lagged models supported a significant relationship between pre-
deployment sleep disturbance and future re-experiencing PTSD symptoms at all time points.
Initial moderation models showed a small moderator effect of combat-stress severity,
though the main predictive relationship between pre-deployment sleep disturbance and
PTSD symptoms remained significant. The moderator effect was not significant in the
replication sample.
Conclusions: The results of this study support pre-deployment sleep disturbance as a risk
factor for development of post-deployment PTSD symptoms. Interventions aimed at
normalizing sleep may be important in preventive measures for PTSD.
Alteración del sueño previa-al-despliegue es un predictor significativo de
los síntomas de reexperimentación posteriores-al-despliegue
Antecedentes: El insomnio es común en los miembros del servicio y está asociado con
muchos problemas de salud mental y física. Recientemente, se han utilizado datos long-
itudinales para evaluar el impacto de las alteraciones del sueño en los resultados de salud
mental. Estos estudios han demostrado consistentemente las relaciones entre las altera-
ciones del sueño y el desarrollo de enfermedades mentales.
Objetivo: El presente estudio examinó la relación longitudinal entre el trastorno del sueño
y la sintomatología del TEPT en una cohorte de infantes y médicos de Marina desplegados
en Irak y Afganistán evaluados antes del despliegue, así como a los 3 y 6 meses posteriores
al despliegue. Además, nuestro objetivo fue investigar hasta qué punto estas relaciones son
moderadas por la gravedad del estrés de combate, y en qué medida estos hallazgos se
replican en una segunda cohorte separada de marinos y médicos de la Marina evaluados
con medidas idénticas antes del despliegue y dentro de los 3 meses de regreso.
Método: El presente estudio empleó modelos de trayectorias de variables latentes para
examinar las relaciones entre la alteración del sueño previa al despliegue y los síntomas de
reexperimentación posterior al despliegue. Se llevaron a cabo modelos iniciales de trayec-
torias de retardo cruzadas en muestras de descubrimiento y replicación para validar las
relaciones predictivas hipotéticas. Los modelos de seguimiento de las trayectorias de
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moderación se llevaron a cabo para incluir el efecto de la gravedad del estrés de combate
en estas relaciones.
Resultados: Los modelos iniciales de retardo cruzado respaldaron una relación significativa
entre la alteración del sueño previa al despliegue y los síntomas futuros de TEPT que se
vuelven a experimentar en todos los momentos. Los modelos de moderación iniciales
mostraron un efecto moderador pequeño de la gravedad del estrés de combate, aunque
la principal relación predictiva entre la alteración del sueño previa al despliegue y los
síntomas de TEPT se mantuvo significativa. El efecto moderador no fue significativo en la
muestra de replicación.
Conclusiones: Los resultados de este estudio respaldan que la alteración del sueño previa al
despliegue es un factor de riesgo para el desarrollo de síntomas de TEPT posterior al
despliegue. Intervenciones dirigidas a normalizar el sueño pueden ser importantes en
cuanto a medidas preventivas para el TEPT.
部署前睡眠障碍显著预测部署后再体验症状
背景：失眠在服役人员中常见且与许多身心健康问题有关。最近，纵向数据被用于评估
睡眠障碍对心理健康结果的影响。这些研究一致揭示了睡眠障碍与精神疾病发展的关
系。
目的：本研究考查了被派遣到伊拉克和阿富汗的海军医护兵在部署前和部署后3个月、6
个月的睡眠障碍和创伤后应激障碍症状之间的纵向关系。此外，我们旨在考查这些关系
在多大程度上受到战斗应激严重程度的影响。并通过让另一个海军医护兵独立群体在其
部署前和在回国后3个月内接受相同测评考查这些结果在多大程度上能够重复。
方法：本研究采用潜变量路径模型来考查部署前睡眠障碍与部署后再体验症状之间的关
系。在探索样本和重复样本上应用初始交叉滞后路径模型以验证假设的预测关系。随后
在调节路径模型中将战斗应激严重程度对这些关系的影响纳入。
结果：初始交叉滞后模型在所有时间点都支持了部署前睡眠障碍与未来出现再体验这一
PTSD症状之间显著相关。虽然部署前睡眠障碍对创伤后应激障碍症状的主预测关系仍然
显著，初始调节模型显示战斗应激严重程度的调节效应较小。调节效应在重复样本中不
显著。
结论：本研究的结果支持部署前睡眠障碍作为部署后PTSD症状发展的一个风险因子。旨
在使睡眠正常化的干预在创伤后应激障碍的预防措施中可能很重要。
1. Introduction
Sleep is an essential, phylogenetically conserved biolo-
gical function that is in part genetically determined, but
that is impacted as well by an array of non-genetic
environmental factors, such as shift work, long-
distance travel, noise, physical and emotional stress
(Lane et al., 2017; Stein et al., 2018). Individual variation
in insomnia, and sleep-related traits such as sleep dura-
tion and quality, are of high medical interest, as sleep
disturbance is both common and ubiquitousworldwide,
and is associated with a range of negative physical and
mental health outcomes, and with increased mortality
(Bramoweth&Germain, 2013; Irwin&Opp, 2017; Roth
et al., 2011). Sleep disturbance can be characterized by
the presence of insomnia symptoms that are bother-
some and result in daytime consequences (i.e. fatigue
and depressedmood), and/or presence of dissatisfaction
with quality or quantity of sleep.
A growing body of research has shown that USA
(US) military personnel are at elevated risk for insuf-
ficient sleep and poor sleep quality, with rates of sleep
disturbance higher than rates in civilians (Klingaman,
Brownlow, Boland, Mosti, & Gehrman, 2018; RAND
Corporation; 2015). These research findings are con-
sistent with results of sleep study in Canadian and
European military cohorts, although mixed results
have also been reported (Danker-Hopfe et al., 2017;
Pettersson, Saers, Lindberg, & Janson, 2016; Reijnen,
Rademaker, Vermetten, & Geuze, 2015; Richardson,
Thompson, & King et al., 2017). Based on a recent
study that assessed pre-deployment psychosocial vari-
ables and insomnia complaints (defined as an
Insomnia Severity Index ≥15; Morin, Belleville,
Belanger, & Ivers, 2011) in soldiers located at Ft.
Hood, clinically significant sleep disturbance
occurred in about one of five of the soldiers prior to
their combat deployment and was associated with
a wide array of psychosocial stressors and mental
and physical health problems (Taylor et al., 2016).
These findings are similar to those observed in sol-
diers with sleep disturbance in the larger Army
STARRS study (n = 21,499) (Klingaman et al., 2018;
Taylor et al., 2016). As noted in both studies, in
comparison to civilians, military service members
face a number of environmental stressors and chal-
lenges that may place them at increased risk for sleep
disturbance including, but not limited to, frequent
overnight and early-morning shift work, exposure to
deployment stress, frequent changes in duty assign-
ments, and in duty station (Klingaman et al., 2018;
Taylor et al., 2016).
Over the past decade, longitudinal data have begun
to be used prospectively to assess the impact of sleep
disturbance on mental health outcomes. Millennium
Cohort researchers showed that not only were insomnia
complaints significantly associated with poorer physical
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health and poorer function (i.e. more lost work days,
lower odds of deployment, earlier discharge, and more
health-care utilization) in a broad range of active duty
military personnel, but that the personnel with poorer
pre-deployment sleep quality were more likely to
(newly) screen positive for mental health disorders
after a deployment (Gehrman et al., 2013; Seelig et al.,
2016). Similarly, based on prospective evaluation of
a National Guard cohort, Koffel et al., showed that pre-
deployment daytime and nighttime sleep complaints
significantly contributed to PTSD and depression sever-
ity up to 2 years after deployment. However, sleep
disturbance did not predict substance use, which
together led to suggestion that sleep disturbance is
a risk factor for internalizing disorders (e.g. PTSD and
depression) but not externalizing disorders (Koffel,
Polusny, Arbisi, & Erbes, 2013). In 453 Dutch service
members who were assessed before deployment to
Afghanistan, nightmares, but not insomnia complaints,
predicted PTSD at 6-months post-deployment (van
Liempt, van Zuiden, Westenberg, Super, & Vermetten,
2013). However, given that the study researcher used six
questions extracted from the Symptom Checklist (SCL-
90) and the Self-Reported Inventory for posttraumatic
stress disorder (SRIP) to assess the pre-deployment
parameters, overlap in the pre-deployment comparator
and outcome variables may have been a study limita-
tion. However, more recently, a well-designed prospec-
tive analysis of soldier participants of the Army
STARRS study (n = 4,645) showed pre-deployment
insomnia to be a significant risk contributor to post-
deployment PTSD and to suicidal ideation after con-
trolling for relevant baseline and deployment-related
factors (Wang et al., 2019). And, Biddle et al. used
a prospective design in a general civilian population of
sleep disturbance to control for study confounders (i.e.
individual demographics, traits and past and current
mental health as covariates in the analysis) in such
a way as to disentangle the association between prior
sleep disruption (insomnia) and subsequent develop-
ment of mental illness (Biddle, Kelly, Hermens, &
Glozier, 2018). The authors found that sleep distur-
bance maintained a consistent predictive relationship
with future mental illness unaccounted for by its asso-
ciation with past and current mental illness symptoms.
Here we aimed to examine if deployment-
related PTSD symptomology can be predicted
prospectively by sleep disturbances soon after the
return from deployment and/or even as early as
before deployment, and to replicate currently
published findings. To that end, the present
study aim is to examine the longitudinal relation-
ship between sleep disturbance and PTSD symp-
tomatology in a cohort of Marines and Navy
Corpsmen deployed to Iraq and Afghanistan
who were assessed prior to deployment, as well
as 3 and 6 months after their return home.
Additionally, our aim is to investigate the extent
to which these relationships are moderated by
combat-stress severity. Further, we have sought
to replicate these findings using a second, sepa-
rate cohort of Marines and Navy corpsmen
assessed with identical measures prior to deploy-
ment and within 5–7 months of return from
combat. As sleep disturbance is a fundamental
aspect of PTSD as a syndrome, prospective asso-
ciations between sleep disturbance and future
PTSD diagnosis or total symptom rating scores
may contain an element of confound due to asso-
ciations between sleep disturbance and related
symptoms at both time points. To address this,
we employed a principal components analysis as
an empirical method to separate symptoms that
were highly related to sleep disturbance from less
related symptoms. Thus, here we focus on predic-
tion of re-experiencing symptoms, which emerged
as the PTSD symptom cluster most distinct from
those symptoms associated with sleep.
2. Methods
2.1. Participants
Data were extracted from a prospective longitudinal
study of Marines and Navy corpsmen stationed in
southern California (data collected 2008–2013). For
the initial analysis, 2,594 participants completed the
relevant assessment measures. Of these, 190 were
excluded due to elevated PTSD and/or depression
symptoms prior to deployment (see below for symp-
tom-based exclusion criteria). Thus, 2,404 participants
were included in the analysis. All participants were
recruited from Infantry battalions, which were all male
at the time of data collection; the pre-deployment mean
age was 22.77 (SD = 3.52). Assessments were gathered
as part of a larger study aimed at identifying markers of
risk and resilience for combat-stress injuries (Marine
Resiliency Study (MRS); Baker, Nash, & Litz et al.,
2012). Participants were assessed approximately 1
month prior to a 7-month deployment to Iraq or
Afghanistan, and again at 3 and 6 months following
return from deployment. For the replication analysis,
data were collected from a separate cohort of 1,040
additional participants (2012 to 2013). Of these, 102
were excluded due to elevated PTSD or depression
symptoms prior to deployment. Thus, 938 participants
were included in the replication analysis. Being
recruited from Infantry battalions, all participants
were (again) male, with a mean age at pre-deployment
of 21.87 (SD = 2.76). Longitudinal assessments for the
replication cohort were assessed on average 4 weeks
(SD = 4.9) prior to deployment and 22 weeks
(SD = 22.4) weeks following deployment (Marine
Resiliency Study II; Mooreet al., 2017) This study was
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approved by the institutional review boards of the
University of California, San Diego; the Veterans
Affairs San Diego Research Service; and the Naval
Health Research Centre and written informed consent
were obtained from all participants.
2.2. Measures
2.2.1. All measures were completed at each time
period
2.2.1.1. PTSD. Posttraumatic stress disorder symp-
toms were assessed using the Clinician Administered
PTSD Scale, DSM-IV Version (CAPS; Blake et al.,
1995). The CAPS is a structured interview used to
make a categorical PTSD diagnosis with a total score
scale ranging from 0 to 136. PTSD diagnosis at pre-
deployment was assessed using the partial PTSD cri-
teria articulated by Stein, Walker, Hazen, and Forde
(1997) and used in past research with this sample
(Acheson et al., 2015). Partial criteria, rather than
full diagnostic, criteria were used due to the relative
health of the sample. Criteria for a diagnosis of ‘par-
tial PTSD’ were the presence of at least 1 B symptom
(generally re-experiencing), 2 C symptoms (generally
avoidance), and 2 D symptoms (generally hyperarou-
sal). Interrater reliability in the MRS sample was high
for both CAPS total score (ICC = .99) and PTSD
diagnosis (kappa = .714). All interviews were con-
ducted by study personnel who were trained, certi-
fied, and supervised by a licenced psychiatrist (DGB;
Baker et al., 2012).
2.2.1.2. Combat stress. Stressful experiences during
combat were assessed at approximately 1-month follow-
ing return from deployment with four scales from the
Deployment Risk and Resilience Inventory-2 (DRRI-2;
Vogt et al., 2013; Post-Battle Experiences, Combat
Experiences, Deployment Concern, and Difficult Living
andWork Environment). A composite score was created
from standardized scores on each subscale, with a mean
score approximating zero (Glenn et al., 2017).
2.2.1.3. Depression. Depression symptoms were
assessed using the Beck Depression Inventory 2
(BDI-2; Beck, Steer, Ball, & Ranieri, 1996). The
BDI-2 measures the presence of depressive symptoms
during the past 2 weeks with a total score scale ran-
ging from 0 to 63. Consistent with previous research
using the MRS cohort (Acheson et al., 2015), pre-
deployment depression was defined as a BDI-2 score
greater than or equal to 20 to indicate the presence of
at least moderate depression. For the analyses, the
BDI insomnia/hypersomnia item was recoded so
that only insomnia was scored.
2.2.1.4. Anxiety. Anxiety of symptoms was assessed
using the Beck Anxiety Inventory (BAI; Beck & Steer,
1993). The BAI measures the presence of anxiety
symptoms during the past week and effectively dis-
tinguishes between anxiety vs. depressive symptoms
(Clark, Steer, & Beck, 1994).
2.2.1.5. Dissociative symptoms. Peritraumatic disso-
ciative symptoms were assessed with the
Peritraumatic Dissociative Experiences Scale (PDEQ;
Agorastos et al., 2013). This measure has a range of
0–50, with higher score representing increased
dissociation.
2.2.1.6. Affectivity. Affect was measured with the
Positive and Negative Affect Schedule (PANAS;
Watson, Clark, & Tellegen, 1988). The PANAS is
a self-report questionnaire which measures both posi-
tive and negative affect over the past week. It has
been assessed to have high reliability and validity
(Crawford & Henry, 2004).
2.2.1.7. General health. The Short Form Health
Survey is a reliable and valid short measure of general
health (SF-12; Ware, Kosinski, & Keller, 1996). The
questions are combined, scored, and weighted to give
an overall picture of physical health, mental health,
and overall health-related quality of life.
2.2.2. Item selection by principal components
analysis
As sleep disturbance is a fundamental symptom of
PTSD, assessments of the relationship between sleep
and PTSD symptoms may be confounded due to
variance associated with sleep being present in both
constructs. Thus, it was necessary to assure that indi-
cators of sleep disturbance and PTSD represented
maximally distinct constructs. To this end, we
employed a principal components analysis (PCA) on
the initial sample with varimax rotation on all 102
individual measure items to identify those items
which were indicators of PTSD symptoms but that
did not load on the same component as items indi-
cative of sleep disturbance.
Full details of the PCA are included in supplemental
materials. In short, a nine-component solution was
identified which accounted for 38% of variance in
items. A six-item component was identified that we
label ‘re-experiencing symptoms’ as this component
contained all 5 items of the CAPS representing the re-
experiencing cluster of symptoms as well as an item
indexing efforts to avoid trauma reminders. No items
indexing sleep disturbance loaded onto this component.
The three items indexing sleep disturbance loaded onto
a larger factor containing a number of items from
different measures which all appeared to index domains
of behavioural/emotional hyperactivation/arousal. As
this component also included CAPS items indexing
additional avoidance and hyperarousal symptoms,
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these items were not included in the current analysis in
order to avoid conflating PTSD symptom and sleep
disturbance constructs. Thus, we reduced our data set
from the full 102 items to 3 items serving as indicators
of the construct ‘sleep disturbance’ (BDI insomnia;
CAPS average hours of sleep; CAPS difficulty falling
or staying asleep), and 6 items from the CAPS serving as
indicators of the construct ‘re-experiencing symptoms’
(B1: intrusive thoughts; B2: nightmares; B3 flashbacks;
B4: cue distress; B5: cue reactivity; C1: avoidance of
thoughts/feelings/conversations). Thus, only these
items were examined in our predictive models given
the results of the PCA and the scope of our analytic
aims. Of note, the constructs applied to our predictive
models represented continuous self-report ratings of
symptoms, and DSM-derived diagnosis of PTSD or
Insomnia Disorder was not determined.
2.3. Data analysis
2.3.1. Cross-lagged panel model
Structural Equation Modelling (SEM) was employed
to build an autoregressive cross-lagged panel model
exploring the longitudinal relationships among con-
structs (Sleep Disturbance and Re-Experiencing
Symptoms) using latent variables. Model parameters
were estimated using SPSS AMOS software.
Individual measure items identified via PCA were
used as indicators of latent constructs. Model fit was
assessed using the Comparative Fit Index (CFI) as
well as the Root Mean Square Error of
Approximation (RMSEA) criteria. CFI values in the
range of .9 to .95 and above, and RMSEA values of
.08 to .06 and below are generally considered indica-
tors of acceptable model fit (Hooper, Coughlan, &
Mullen, 2008).
2.3.2. Moderation analyses
In response to the results of our original cross-lagged
panel model, two additional path models were con-
structed to examine the effect of pre-deployment sleep
on re-experiencing symptoms at both 3 and 6 months
post-deployment separately. Additionally, the moderat-
ing effect of combat-stress severity was included in
these models using established guidelines for construct-
ing interaction terms in SEM (Little, Bovaird, &
Widaman, 2006). The replication model included pre
and post-deployment time points. CFI and RMSEA
criteria were again used to assess model fit.
3. Results
3.1. Initial cross-lagged panel model
The cross-lagged panel model with standardized path
coefficients can be seen in Figure 1. Model fit was good
with a CFI = .97 and RMSEA = .025 (90%CI .022 – .028).
Sleep disturbance at baseline was a significant predictor
of re-experiencing symptoms at 3-month and sleep dis-
turbance at 3-month was a significant predictor of re-
experiencing symptoms at 6-month (βs = .18; ps<.001).
Re-Experiencing symptoms at pre-deployment were not
significant predictors of sleep disturbance at 3-month,
though re-experiencing symptoms at 3-month did pre-
dict sleep disturbance at 6-month. However, this effect
was relatively small (βs<.07; p < .05).
3.2. Replication of cross-lagged panel model
The replicated cross-lagged panel model with standar-
dized path coefficients can be seen in Figure 2. Model fit
was again good with a CFI = .95 and RMSEA = .04 (90%
CI .035 – .046). Sleep disturbance at Pre-Deployment was
a significant predictor of re-experiencing symptoms at
Post-Deployment (β = .17; p < .001). Re-Experiencing
symptoms at pre-deployment were not a significant pre-
dictor of sleep disturbance Post-Deployment (βs = .08;
p < .06).
3.3. Initial moderation models
The moderation path models can be seen in
Figures 3 and 4. Model fit was good for both
models with CFIs of .96 and .94 and RMSEAs of
.03 (90%CI .027 – .033) and .032 (90%CI .029 –
.035). For the 3-month model, pre-deployment
sleep disturbance continued to be a significant
predictor of re-experiencing symptoms at
3-month (β = .15; p < .001), and combat-stress
severity was also a significant predictor of symp-
toms (β = .39; p < .001). Additionally, there was
a significant effect of the interaction terms such
that the relationship between sleep disturbance re-
experiencing symptoms was stronger in the pre-
sence of greater combat-stress severity (β = .06;
p < .04). A similar pattern of results was obtained
in the 6-month model, with pre-deployment sleep
disturbance (β = .22; p < .001) and combat-stress
severity (β = .3; p < .001) predicting re-
experiencing symptoms at 6-month. Further, the
moderating effect of combat-stress severity on the
relationship between pre-deployment sleep distur-
bance and re-experiencing symptoms at 6-month
remained (β = .08; p < .02).
3.4. Replication of moderation model
The replication moderation path model can be seen in
Figure 5. Model fit was good with CFI of .91 and
RMSEA of .05 (90%CI .041 – .051). Pre-deployment
sleep disturbance was a significant predictor of re-
experiencing symptoms at post-deployment (β = .13;
p < .002), and combat-stress severity was also
a significant predictor of symptoms (β = .30; p < .001).
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However, there was not a significant effect of the inter-
action term in the replicationmodel (β = −.006; p = .89).
4. Discussion
The present large-scale study builds upon recent
work to further elucidate the longitudinal sleep dis-
turbance-PTSD symptomology relationship among
military personnel. Our findings illustrate that sleep
disturbance prior to potential trauma exposure (i.e.
military combat deployment) predicts re-
experiencing symptoms at 3-months post-
deployment, and that sleep disturbance at 3 months
predicts re-experiencing symptoms 6 months post-
deployment. In the larger cohort, the relationship
between pre-deployment sleep disturbance and future
re-experiencing symptoms at both time points was
moderated by the severity of combat exposure,
though this effect was modest. However, this mod-
erator effect was not found in our replication sample.
The lack of a moderator effect in the replication
sample may have been due to either its smaller size
(n = 2,404 vs. 1,040) or to differences in the post-
deployment assessment time points (3 and 6 months
post-deployment vs. about 5–7 months post-
deployment). Our findings failed to support
a robust relationship between re-experiencing
symptoms and future sleep disturbance at any time
point, thus illustrating sleep disturbance to be
a fundamental mechanism in PTSD emergence
which is only moderately altered by subsequent
trauma exposure.
Our findings demonstrate that pre-deployment
sleep disturbance predicts subsequent re-
experiencing symptoms and, thus, may be impli-
cated in the development of core PTSD symptoms.
Our findings align with those of extant studies
investigating pre-trauma sleep impairment and sub-
sequent development of psychiatric illnesses, such as
PTSD (Biddle et al., 2018; Bryant, Creamer,
O’Donnell, Silove, & McFarlane, 2010; Gehrman
et al., 2013; Wang et al., 2019). As per the diathesis-
stress conceptualization of PTSD (McKeever & Huff,
2003), pre-deployment sleep disturbance may thus
predispose to post-deployment development of re-
experiencing symptoms following onset of trauma
experienced during military combat.
The genetic and biological mechanisms respon-
sible, and their relationship to, pre-existing sleep
disturbance are yet to be fully elucidated. GWAS
studies based on self-report sleep quality and
accelerometer data confirm the heritability of
sleep disturbance and reveal a number of candi-
date risk loci (Hill, O’Connor, & Shirasu-Hiza,
Figure 1. Standardized coefficients for autoregressive cross-lagged panel model on the initial (MRS I) sample. Observed
variables are indicated by rectangular nodes, while latent constructs are indicated by oval-shaped nodes. Observed variables B1-
C1 indicate specific items from Clinician Administered PTSD Scale (CAPS), DSM IV version (see PCA results for specific items).
Modelled correlated error for repeated measures has been omitted for clarity of presentation (values range .04 – .33). Modelled
correlated error between latent constructs at 3 and 6-month time points has likewise been omitted for clarity (values .4 and .33,
respectively). * = p < .05, ** = p < .001.
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2018; Joiner, 2018; Jones et al., 2019; Lane et al.,
2017; Stein et al., 2018). These specific risk-genes
and their physiological contributions to PTSD risk
are yet to be adequately investigated, although
genes identified in GWAS-sleep studies are cur-
rently being studied for their role in physiological
contribution to fear learning and PTSD-risk
(Feusner et al., 2001; Krzyzewska et al., 2018; Li
et al., 2019; Soya & Sakurai, 2018).
While risk-genes may ultimately be shown to con-
tribute to polygenic risk for PTSD development in
poor sleepers and their mechanistic contributions to
physiology clarified, inflammation, shown to contri-
bute to development and maintenance of mental
health disorders may be an important mechanism
for PTSD development in sleep-disturbed service
members, although persistent disturbances of sleep
appear to be necessary for inflammatory signalling
to be translated into an increase in measurable sys-
temic markers of inflammation (Irwin, Olmstead, &
Carroll, 2016; Irwin & Opp, 2017). Both sleep dis-
turbance and shorter sleep duration (but not the
extreme of short sleep) are associated with higher
levels of inflammatory signalling (i.e. increased
C-reactive protein; CRP, interleukin-6; IL-6) (Irwin
et al., 2016). There is already considerable evidence
for a significant association between inflammation
and PTSD diagnosis (Breen et al., 2018; Brudluy
et al., 2015; Michopoulos et al., 2015; Miller et al.,
2018; Spitzer et al., 2010). Moreover, there is prospec-
tive evidence that inflammation may be a risk factor
for PTSD emergence (Breen et al., 2015; Eraly et al.,
2014) and that it affects fear circuits and processes
(Deslauriers, Powell, & Risbrough, 2017). Taken
together with findings of the present study, it is
thus conceivable that pre-deployment sleep distur-
bance among military personnel may have resulted
in an increase in inflammatory signalling which pre-
disposed to the development of re-experiencing
symptoms following trauma exposure (Besedovsky,
Lange, & Haack, 2019). As pre-deployment sleep dis-
ruption is prevalent among military personnel (Xue
et al., 2015), our findings demonstrate the importance
of achieving adequate sleep prior to combat exposure.
Figure 2. Standardized coefficients for the replicated (MRS II) autoregressive cross-lagged panel model. Observed variables are
indicated by rectangular nodes, while latent constructs are indicated by oval-shaped nodes. Observed variables B1-C1 indicate
specific items from Clinician Administered PTSD Scale (CAPS) DSM IV version (see PCA results for specific items). Modelled
correlated error for repeated measures has been omitted for clarity of presentation (values range −.03 – .43). Modelled
correlated error between latent constructs at post-deployment has likewise been omitted for clarity (.35). ** = p < .001.
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Facilitating improvements in the sleep of military
personnel may thus help protect those deployed to
combat situations from subsequent development of
PTSD.
The finding that sleep disturbance 3 months post-
deployment predicts re-experiencing symptoms 6
months post-deployment illustrates the role of sleep dis-
turbance in the maintenance of PTSD symptomology.
The impaired ability to inhibit learned fear experienced
during combat deployment may be one mechanism that
contributes to the maintenance of re-experiencing symp-
toms. Fear inhibition processes, including fear extinction
and safety learning, are crucial to recovery following
trauma exposure (Careaga, Girardi, & Suchecki, 2016;
Jovanovic, Kazama, Bachevalier, & Davis, 2012). Thus,
these processes comprise a critical aspect of clinical inter-
ventions, such as exposure therapy (Foa, Hembree, &
Rothbaum, 2007). Studies have demonstrated
a relationship between poor sleep consolidation and
fear inhibition ability. In particular, rapid eye movement
(REM) sleep, a stage of sleep is implicated in the regula-
tion of emotional-laden memories (Abel, Havekes,
Saletin, & Walker, 2013). For example, subjects who
had disruption of REM sleep subsequently exhibit lower
levels of fear extinction memory recall (Menz, Rihm, &
Buchel, 2016; Straus, Acheson, Risbrough, &
Drummond, 2017).Additionally, safety learningmemory
recall is dependent on the consolidation of REM sleep
acquired across the previous night (Marshall, Acheson,
Risbrough, Straus, & Drummond, 2014). In the present
study, subject’s reported sleep disturbance 3 months
post-deployment may indicate insufficient consolidation
of REM sleep. Lack of REM sleep, then, maybe impairing
fear extinction and safety learning processes and conse-
quently facilitating the persistence of re-experiencing
symptoms 6 months post-deployment. To this end, the
adequate consolidation of sleep, especially REM sleep,
may be crucial for inhibition of fear learned during com-
bat deployment. However, polysomnographic sleepmea-
surement was not employed in the present study, thereby
limiting our ability to definitively determine whether
poor REM sleep consolidation was indeed
a contributing factor.
Finally, our findings reveal that the relationship
between sleep disturbance and re-experiencing symp-
toms may be moderately dependent on severity of
trauma encountered. This finding is anticipated,
given that severity of trauma exposure is a robust
risk factor for development of PTSD among military
personnel. Similarly, a study of the New York popu-
lation 6 months following September 11 demon-
strated a higher prevalence of PTSD among those
directly involved (Galea, 2003), thus suggesting proxi-
mity to trauma may also contribute to the subsequent
development of PTSD. Thus, while sleep disturbance
may be implicated in the development and
Figure 3. Standardized coefficients for the initial (MRS I) moderation model-predicting re-experiencing symptoms at 3-month
from re-experiencing symptoms at pre-deployment, sleep disruption at pre-deployment, combat-stress experience, and the
interaction between pre-deployment sleep disruption and combat stress. Observed variables are indicated by rectangular nodes,
while latent constructs are indicated by oval-shaped nodes. Observed variables B1-C1 indicate specific items from Clinician
Administered PTSD Scale (CAPS) DSM IV version (see PCA results for specific items). Indicators of the interaction construct
represent the residual of the product of the two items multiply regressed on both individual items in order to isolate variance
accounted for by the interaction. * = p < .05, ** = p < .001.
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Figure 4. Standardized coefficients for the initial (MRS I) moderation model-predicting re-experiencing symptoms at 6-month
from re-experiencing symptoms at pre-deployment, sleep disruption at pre-deployment, combat-stress experience, and the
interaction between pre-deployment sleep disruption and combat stress. Observed variables are indicated by rectangular nodes,
while latent constructs are indicated by oval-shaped nodes. Observed variables B1-C1 indicate specific items from Clinician
Administered PTSD Scale (CAPS) DSM IV version (see PCA results for specific items). Indicators of the interaction construct
represent the residual of the product of the two items multiply regressed on both individual items in order to isolate variance
accounted for by the interaction. * = p < .05, ** = p < .001.
Figure 5. Standardized coefficients for the replicated (MRS II) moderation model predicting re-experiencing symptoms at post-
deployment from re-experiencing symptoms at pre-deployment, sleep disruption at pre-deployment, combat-stress experience,
and the interaction between pre-deployment sleep disruption and combat stress. Observed variables are indicated by
rectangular nodes, while latent constructs are indicated by oval-shaped nodes. Observed variables B1-C1 indicate specific
items from Clinician Administered PTSD Scale (CAPS) DSM IV version (see PCA results for specific items). Indicators of the
interaction construct represent the residual of the product of the two items multiply regressed on both individual items in order
to isolate variance accounted for by the interaction. ** = p < .001.
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maintenance of re-experiencing symptoms in military
personnel (e.g. via inflammatory processes and fear
inhibition impairment, respectively), development of
such symptomology may depend on the precipitating
influence of the traumatic event. The link between
sleep disturbance and re-experiencing symptoms,
then, maybe of particular concern to individuals
who’s occupation places them at risk of experiencing
high-severity trauma, such as military personnel
(Richardson, Frueh, & Acierno, 2010) and those
employed within the emergency services (Berger
et al., 2012). Emphasizing the importance of sufficient
sleep consolidation and screening for sleep difficulties
in individuals at-risk for high-severity trauma is thus
particularly critical for the prevention as well as treat-
ment of PTSD within these high-risk populations.
The current study has a number of limitations that
should be mentioned. The studies from which these
data were extracted did not include a specific sleep
quality measure, such as the Insomnia Severity Index
(ISI; Morin et al., 2011). Thus, we had to infer sleep
disturbance from items embedded in other measures
(CAPS, BDI). However, it is important to note that
the results of this study are consistent with other
studies demonstrating a predictive link between
sleep disturbance and development of psychiatric
symptoms which did use explicit sleep measures
(Taylor et al., 2016). The lack of an explicit sleep
measure in these studies also necessitated the some-
what unconventional use of a principal components
analysis to select latent variable indicator items as
sleep items from the CAPS at baseline would have
been confounded with PTSD total score. While this
method may not be perfect in eliminating overlap
between sleep disturbance and PTSD symptoms, it
provided a data-driven method of maximizing the
distinction, and we have further attempted to address
this by including the baseline correlation between
latent variables in our models.
5. Conclusion
The present study provides longitudinal evidence to
support the critical predisposing and perpetuating
influence of sleep disturbance pre and post-
deployment, respectively, in subsequent development
of PTSD symptomology (i.e. in this case, re-
experiencing symptoms). Thus, improvement of
sleep pre and post-potential trauma exposure may
aid in the prevention of symptoms associated with
PTSD among military personnel. This notion is
encouraging, as sleep is generally considered
a modifiable variable, especially when clinical inter-
ventions are sought (e.g. cognitive behavioural ther-
apy for insomnia (van Straten et al., 2017). Improved
understanding of the mechanisms of sleep distur-
bance and the implementation of sleep-specific
interventions and treatment may thus be of critical
importance to military personnel in the prevention
and treatment of PTSD.
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